hereditary angioedema

Hurdles lined up on track for race
Biotech

BioCryst CEO sets out strategy after ending internal discovery

BioCryst CEO Charlie Gayer told Fierce the company is “not getting away from science and R&D” despite shutting down its internal discovery efforts.
Will Maddox Aug 14, 2026 10:07am
closed close

BioCryst ends internal programs in pivot to partnerships

Jun 29, 2026 10:30am
Eclipse

Intellia touts ‘paradigm-shifting’ HAE data

Jun 15, 2026 10:37am
Hand with tweezers editing DNA

Intellia races in vivo CRISPR therapy to FDA after phase 3 win

Apr 27, 2026 9:24am
An arrow incrementally going up stairs before pointing straight up Blue background

Pharvaris clocks a pivotal win in race for rapid HAE relief

Dec 3, 2025 9:10am
Three blocks displaying from left to right a person a handshake and another person

BioCryst inks $700M Astria deal to rival Takeda in rare disease

Oct 14, 2025 10:30am